Increased 5α-Reductase and Normal 11β-Hydroxysteroid Dehydrogenase Metabolism of C19 and C21 Steroids in a Young Population with Polycystic Ovarian Syndrome
- 1 January 2000
- journal article
- clinical trial
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 13 (3) , 253-9
- https://doi.org/10.1515/jpem.2000.13.3.253
Abstract
To test the hypothesis that 5alpha-reductase (5alphaR) and 11beta-hydroxysteroid dehydrogenase (11beta-HSD) activity are increased in adolescent and young-adult women with PCOS and that an altered regulation of the hypothalamic-pituitary-adrenal (HPA) axis occurred in these subjects. Prospective non-randomized study in an academic research environment. Eleven women, aged 14 to 25 years, were studied who were at least one year post-menarche and who had a diagnosis of PCOS based on a history of oligomenorrhea and elevated total and or free serum testosterone. 24-Hour urinary metabolites were assessed in nine subjects and five underwent stimulation with ovine corticotropin releasing factor (oCRF). C19 and C21 steroid urinary metabolite 5-alpha/5-beta pairs, 11-oxo/11-hydroxy products and the ratio of the total 5-alpha/5-beta reduced and 11-oxo/11-hydroxy products were compared to values in control women. Urinary cortisol (F) (sum of conjugated and free, and free F) and total F metabolites (the sum of THE, THF, 5alpha-THF, cortolones, and cortols) were determined. A 1 microg/kg oCRF stimulation test was performed with timed samples determined for plasma ACTH and serum F levels. The 24-hour total and free urinary F were not different from control. However, the total F metabolites were markedly elevated (7922+/-2666 vs 5418+/-1549 microg/24 h, p<0.01). A marked increase in the total 5-alpha reduced C19 and C21 metabolites was observed in the PCOS population vs control (5084+/-1977 vs 2681+/-1188 microg/24 h, p<0.01). The total urinary 11-oxo/11-hydroxy metabolite ratio was not different, p=0.23. The basal values and response of both ACTH and F to oCRF stimulation were not different from those of controls. There is a marked increase in 5alphaR metabolism of both C19 and C21 steroids in younger women with PCOS.Keywords
This publication has 20 references indexed in Scilit:
- Adrenal Involvement in Polycystic Ovary SyndromeSeminars in Reproductive Medicine, 1997
- Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography/mass spectrometry with stable isotope-labeled internal standardsSteroids, 1996
- Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.Proceedings of the National Academy of Sciences, 1995
- The genetics of polycystic ovary syndromeThe American Journal of Medicine, 1995
- Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretionJournal of Clinical Endocrinology & Metabolism, 1995
- Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndromeJournal of Clinical Endocrinology & Metabolism, 1994
- Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenismJournal of Clinical Endocrinology & Metabolism, 1993
- Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension researchThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- 5 α-reductase activity in polycystic ovary syndromeThe Lancet, 1990
- CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMENJournal of Clinical Endocrinology & Metabolism, 1961